Market Outlook

The U.S. Ambulatory Surgery Center Anesthesia Machines Market is estimated at approximately USD 0.32 billion in 2025 and is projected to reach approximately USD 0.72 billion by 2035, expanding at an 8.45% CAGR during the forecast period 2026–2035. Historical market value increased from approximately USD 0.23 billion in 2021 to USD 0.30 billion in 2024, supported by the post-pandemic normalization of elective procedures, accelerating migration of surgery from hospital outpatient departments to freestanding ambulatory surgery centers, development of new orthopedic and multispecialty ASCs, and replacement of aging anesthesia workstations. All monetary values in this report are expressed in USD billions.

The addressable clinical infrastructure behind this market is substantial. The United States has more than 6,500 Medicare-certified ambulatory surgery centers, and U.S. ASCs perform more than 23 million outpatient procedures annually. ASCs already account for roughly 80% of Medicare cataract removals and approximately 50% of Medicare colonoscopies, illustrating how deeply the site-of-care model has penetrated high-volume procedural specialties.

Unlike hospital anesthesia equipment procurement, ASC purchasing is governed by a highly disciplined economic model. Surgery centers have limited physical space, compressed procedure schedules, fewer layers of clinical engineering support, and strong pressure to generate acceptable returns on each operating room. Consequently, an ASC generally does not require the most feature-heavy anesthesia workstation available. It requires a platform that can safely manage its targeted patient population, start quickly, support rapid turnover, minimize anesthetic-agent consumption, simplify daily checks, integrate with essential monitoring, and remain dependable without creating excessive maintenance expense.

The market is nevertheless moving upward in technology intensity. Orthopedic procedures, spine interventions, selected cardiovascular procedures, bariatric surgery, advanced ENT, urology, gynecology and complex general surgery are increasingly being evaluated for outpatient settings. CMS policy is reinforcing the broader transition. For calendar year 2026, CMS added 289 procedures to the ASC Covered Procedures List and another 271 codes associated with procedures removed from the inpatient-only list, expanding the universe of procedures that may become commercially relevant to appropriately equipped ASCs.

As procedure complexity rises, anesthesia-machine selection is moving away from a basic capital-equipment decision toward an operating-room productivity decision. Facilities are comparing equipment based on low-flow capability, advanced ventilation, automated checkout, gas monitoring, interface familiarity, electronic documentation, preventive-maintenance requirements, uptime, parts availability, service response and usable life. The result is a favorable replacement and premiumization cycle for compact digital anesthesia systems designed around outpatient economics.

The report’s market definition includes new anesthesia machines and workstations sold into U.S. ASCs, refurbished systems where commercially transacted through professional equipment channels, machine-specific vaporizers and integrated upgrades, and directly associated service and maintenance value. It excludes anesthetic pharmaceuticals, standalone physiologic monitors, infusion pumps, general airway consumables and professional anesthesia-service fees.

 

Introduction

According to the U.S. Ambulatory Surgery Center Anesthesia Machines Market Report, anesthesia equipment has become a strategically important part of the infrastructure supporting America’s shift toward decentralized surgical care. An ASC is fundamentally different from an acute-care hospital. Medicare defines the ASC model around surgical services for patients who do not require hospitalization, with the expected duration of services generally not extending beyond 24 hours after admission.

That operating model makes anesthesia particularly consequential. Successful ambulatory surgery depends on appropriate patient selection, predictable induction, physiologic stability, efficient emergence, effective postoperative recovery and timely discharge. A machine that contributes to delayed starts, complicated checks, unreliable ventilation, excessive gas consumption or difficult troubleshooting can undermine an ASC’s throughput economics even if its acquisition price is attractive.

The commercial market is therefore shaped by three overlapping requirements: clinical safety, room productivity and lifecycle economics.

Clinical safety requires the equipment to support reliable delivery of inhalational anesthesia, oxygenation, ventilation and monitoring across the facility’s intended patient population. CMS conditions for ASC coverage also require individualized evaluation of procedure and anesthesia risk before surgery, reinforcing the importance of matching facility capability with patient acuity rather than assuming every reimbursable procedure is appropriate for every ASC.

Room productivity is equally important. ASC profitability depends heavily on schedule utilization and turnover. Equipment must be intuitive enough for anesthesia teams working across multiple facilities, fast enough to check and prepare between operating sessions, and flexible enough to accommodate different surgical specialties without extensive reconfiguration.

Lifecycle economics form the third component. Independent and physician-owned ASCs often operate under tighter capital budgets than large academic hospitals. Procurement committees consequently examine the expected service life of the machine, preventive-maintenance cost, availability of local field engineers, vaporizer maintenance, replacement parts, software licensing, compatibility with existing monitors, training requirements and residual value.

These considerations explain why the U.S. ASC anesthesia-machine market is not simply a smaller version of the hospital market. The optimal ASC platform is increasingly a purpose-fit system: sufficiently sophisticated for expanding outpatient case complexity but economically calibrated to a high-throughput, lower-overhead environment.

The broader ASC sector provides a strong structural foundation. Fee-for-service Medicare program and beneficiary spending on ASC services reached approximately USD 7.5 billion in 2024, while the number of ASCs expanded by more than 2% annually on average from 2019 through 2024. ASC surgical-procedure volume per fee-for-service beneficiary also increased by 3.5% in 2024.

These trends create both a larger installed base and a more intensively utilized installed base of anesthesia equipment.

 

Key Market Drivers: What’s Fueling the U.S. Ambulatory Surgery Center Anesthesia Machines Market Boom?

The first major driver is the continuing migration of surgical procedures away from hospital operating rooms. ASCs provide same-day procedures with lower facility overhead and, for many services, lower Medicare and patient cost sharing. Analysis published in 2026 estimated that ASCs generated approximately USD 27.9 billion in Medicare savings between 2019 and 2024, while roughly 7 million Medicare procedures were performed in ASCs in 2024.

For anesthesia-equipment manufacturers, site-of-care migration creates demand through two mechanisms. New facilities need an initial equipment fleet, while established facilities expanding into higher-acuity specialties need to replace or upgrade machines originally selected for narrower procedural profiles.

A second major driver is orthopedic outpatient migration. Total joint replacement, sports medicine, extremity surgery and increasingly sophisticated spine procedures have become strategically important to the ASC industry. These cases can involve longer operating times, older patients, obesity, obstructive sleep apnea and more demanding ventilation requirements than traditional ophthalmology or endoscopy. Anesthesia equipment capable of lung-protective ventilation, precise tidal-volume delivery, reliable gas monitoring and rapid emergence becomes more valuable as these procedures move into surgery centers.

A third driver is the growth of multispecialty ASCs. A single-specialty ophthalmology or endoscopy center can standardize around relatively predictable cases. A multispecialty ASC may handle orthopedics in the morning, ENT later in the day, gynecology in another room and pain procedures in a procedure suite. This increases demand for versatile platforms that can accommodate varying patient sizes, anesthetic techniques and ventilation requirements without adding unnecessary operational complexity.

A fourth driver is the expansion of the ASC facility base. More than 6,500 Medicare-certified facilities now operate nationally. Historical data also show consistent expansion: the number of Medicare-certified centers grew from approximately 5,217 in 2011 to 6,087 in 2023. New facilities create greenfield anesthesia-machine demand, while acquisitions and joint ventures often trigger fleet standardization across multiple centers.

A fifth driver is equipment replacement. Many ASCs historically purchased refurbished or previous-generation systems because these offered dependable performance at substantially lower capital cost. That installed base is aging. Replacement decisions increasingly favor equipment with touchscreen interfaces, automated machine checks, electronic fresh-gas control, advanced ventilation, improved ergonomics and connectivity. This does not eliminate the refurbished market; instead, it creates a two-tier ecosystem in which premium multispecialty centers purchase new systems while lower-volume or cost-sensitive centers extend the commercial life of proven platforms through professionally refurbished equipment.

A sixth driver is anesthetic-agent efficiency. Volatile anesthetics represent a recurring operating expense, and waste-gas management has become both an economic and environmental consideration. Low-flow anesthesia reduces fresh-gas requirements and can lower consumption of volatile agents when clinically appropriate. For ASC administrators, even modest reductions in cost per case become relevant when multiplied across thousands of annual procedures.

A seventh driver is anesthesia workforce pressure. Staffing shortages and the increasing use of anesthesia care teams make interface standardization strategically important. Machines with familiar controls, guided checkout, clear alarm architecture and consistent user interfaces can reduce training burden when anesthesiologists, CRNAs or anesthesiologist assistants rotate across multiple facilities. CMS recognizes anesthesia care delivered in ASCs by appropriately qualified clinicians under applicable supervision and state-law requirements, making workforce configuration an important operational variable.

Finally, reimbursement policy is broadening the clinical frontier. CMS’s 2026 expansion of the ASC Covered Procedures List is commercially significant because additional procedures cannot migrate at scale unless facilities possess the clinical infrastructure needed to perform them safely. Anesthesia workstations, physiologic monitoring, emergency capability and postoperative recovery systems are part of that infrastructure.

 

Innovation in Focus: How Manufacturers Are Raising the Bar?

Innovation in the ASC anesthesia-machine market is being directed toward smaller footprints, safer automation, faster workflows, lower gas consumption, better ventilation and simpler data integration rather than toward complexity for its own sake.

Compact architecture is particularly valuable. Every square foot of ASC operating-room space has economic importance, and many freestanding centers were designed with considerably smaller rooms and storage areas than tertiary hospitals. GE HealthCare’s Carestation 620, for example, is positioned as a compact anesthesia system for constrained environments and includes a guided checkout that can be completed in as little as approximately three minutes. Getinge specifically positions its compact Flow-c platform for busy ambulatory surgery centers as well as hospital operating rooms.

Low-flow anesthesia is becoming another major differentiation point. Modern electronic gas delivery, small circuit volumes, advanced gas monitoring and automated control functions allow providers to manage fresh-gas flow more precisely. For facilities performing several thousand cases annually, reduced anesthetic consumption can influence total cost of ownership rather than functioning merely as an environmental feature.

Automated safety functions are also becoming more prominent. Getinge’s Flow family incorporates technologies such as automated gas control and active hypoxia-prevention functions, while GE HealthCare offers advanced electronic control and automated fresh-gas capabilities on higher-tier systems. For ASCs, the strategic value of such features is strongest when they simplify workflows without forcing excessive dependence on complicated menus or costly service infrastructure.

Advanced ventilation is moving downstream from hospitals. Orthopedic, bariatric, pediatric and medically more complex outpatient cases create demand for pressure-controlled ventilation, volume-guaranteed modes, recruitment maneuvers, PEEP management and better respiratory monitoring. Equipment that allows a center to safely broaden its case mix may provide a greater return than a less expensive machine that becomes a limiting factor as physicians introduce new procedures.

Connectivity represents another innovation layer. ASC operators increasingly want anesthesia data incorporated into electronic medical records, anesthesia information management systems and quality documentation. Seamless device connectivity can reduce manual transcription, support compliance and improve retrospective case analysis. For multisite ASC operators, standardized data architecture also assists enterprise procurement and fleet management.

Manufacturers are simultaneously being pushed toward greater serviceability. An advanced workstation that requires long downtime, proprietary maintenance tools or distant field-service coverage may be less attractive in an ASC than a somewhat simpler platform that can be supported quickly. Future competitive differentiation will therefore depend as much on uptime, parts logistics, cybersecurity support and remote diagnostics as on ventilator specifications.

 

Segmentation Insights

The U.S. Ambulatory Surgery Center Anesthesia Machines Market is segmented on the basis of product type, technology, surgical specialty, facility model and procurement model.

 

By Product Type

Integrated Anesthesia Workstations

Integrated anesthesia workstations represent the largest market segment by revenue. These systems combine anesthetic gas delivery, mechanical ventilation, respiratory monitoring, vaporizers, alarms and increasingly digital controls within a unified platform. Their strongest ASC demand comes from multispecialty, orthopedic, ENT, urology, gynecology and higher-acuity centers where facilities want hospital-grade capabilities without hospital-scale footprint.

Premium integrated systems will gain share as more complex procedures migrate to ASCs, although procurement remains highly price-sensitive. Buyers typically prioritize clinically relevant ventilation modes, reliable oxygen and agent monitoring, intuitive controls and service coverage before less frequently used advanced features.

Compact Anesthesia Machines

Compact anesthesia systems are expected to record particularly strong growth. The ASC environment favors machines that preserve usable room space while providing sufficient ventilation and monitoring capabilities. Compact units are attractive for newly developed surgery centers, smaller single-specialty facilities and centers renovating rooms without major infrastructure reconstruction.

The segment also aligns well with ASC economics because compact platforms can be configured without some of the expensive options used by academic hospitals while retaining the core functionality required for safe ambulatory anesthesia.

Portable and Specialty Anesthesia Systems

Portable and specialty systems represent a smaller market but serve procedure rooms, mobile applications and environments where a conventional full-size workstation is unnecessary. Demand is concentrated in limited-space facilities and specialized procedural applications. Growth will remain below that of integrated systems because most general-anesthesia operating rooms continue to require a permanently configured anesthesia workstation.

 

By Technology

Electronic and Digitally Controlled Systems

Electronic anesthesia machines account for a growing share of new equipment spending. Digital gas control, touchscreen interfaces, electronic ventilation, automated checks, data capture and integrated decision-support functions improve standardization and can reduce repetitive manual tasks.

This segment is expected to capture the majority of incremental revenue through 2035 because new-build multispecialty and orthopedic ASCs increasingly specify modern digital equipment rather than purely mechanical designs.

Conventional Pneumatic and Mechanically Controlled Systems

Conventional systems remain important because of their simplicity, durability and familiarity. Many established ASCs continue to operate earlier-generation GE and Dräger platforms with strong service histories. These machines are especially relevant to the refurbished equipment channel.

Growth will be slower as new-equipment purchasing migrates toward electronic platforms, but conventional systems will remain commercially significant because acquisition cost and ease of maintenance are highly valued by independent centers.

Low-Flow and Automated Gas-Control Systems

Low-flow and automated gas-control technologies form the fastest-growing technology subsegment. Their value proposition combines anesthetic-agent savings, environmental benefits and more precise control. Adoption will be strongest in high-volume centers where recurring savings can be demonstrated across thousands of annual cases.

Connectivity-Enabled Systems

Connectivity-enabled machines are moving from optional functionality toward an important enterprise requirement. Hospital-affiliated and corporate ASC networks increasingly seek equipment capable of integrating with electronic anesthesia records, central device-management tools and perioperative information systems. This segment will benefit from continued consolidation of the ASC industry.

 

By Surgical Specialty

Orthopedic and Spine Surgery

Orthopedics and spine represent the most strategically important growth application for anesthesia-machine suppliers. Total joints, sports medicine, hand surgery, foot and ankle surgery and selected spine procedures are increasing the average clinical complexity of ASC case mix.

These centers generally require stronger ventilation capability, dependable agent monitoring and systems suitable for older or medically more complex patients. Orthopedic ASCs also tend to have larger capital budgets because implant-intensive procedures can generate attractive facility economics.

Gastroenterology

Gastroenterology represents one of the largest procedure-volume categories in ambulatory care. Colonoscopy and advanced endoscopic procedures frequently use monitored anesthesia care or deep sedation rather than inhalational general anesthesia, meaning not every GI room requires a fully configured anesthesia machine.

Nevertheless, multispecialty GI centers and facilities performing more complex endoscopy can create meaningful demand, particularly when procedure rooms are designed to accommodate conversion to general anesthesia or broader surgical services.

Ophthalmology

Ophthalmology is one of the most mature ASC specialties, with ASCs performing approximately 80% of Medicare cataract removals. Most ophthalmic surgery is performed with local or regional techniques supported by sedation, so anesthesia-machine intensity per procedure is lower than in orthopedics. However, the sheer size of the ophthalmic ASC infrastructure supports a stable installed base and replacement opportunity.

ENT and Oral/Maxillofacial Procedures

ENT cases create meaningful anesthesia-machine demand because many procedures require general anesthesia and airway management. Pediatric ENT can impose additional ventilation and monitoring requirements. Centers specializing in ENT therefore tend to evaluate machines on tidal-volume accuracy, rapid gas changes, compact configuration and ease of use across adult and pediatric patients.

Urology, Gynecology and General Surgery

These specialties represent an expanding multispecialty opportunity. Laparoscopic procedures, hernia repair, gynecologic surgery and selected urologic procedures are increasingly compatible with outpatient pathways. Their migration raises anesthesia-machine utilization because many require controlled ventilation rather than sedation alone.

Plastic and Other Elective Surgery

Plastic and reconstructive surgery, podiatry, pain intervention and selected specialty procedures form a fragmented but commercially relevant segment. Private-pay and commercially insured case mix can support premium equipment purchasing in certain metropolitan markets, particularly when anesthesia is part of the center’s patient-experience and risk-management strategy.

 

By Facility Model

Independent and Physician-Owned ASCs

Independent and physician-owned centers constitute a large and influential customer category. Procurement is typically highly entrepreneurial and financially disciplined. Buyers evaluate capital equipment in terms of cash flow, financing, expected case volume and maintenance expense. Refurbished machines and value-oriented new systems have relatively strong penetration in this segment.

Hospital and Health-System-Affiliated ASCs

Hospital-affiliated ASCs tend to favor equipment standardization with the parent health system. This benefits manufacturers already installed across the organization because anesthesia teams can work across inpatient and ambulatory locations without learning materially different workflows.

These centers are also more likely to purchase higher-specification equipment because they may accept more complex patients and have stronger access to clinical engineering resources.

Joint-Venture ASCs

Joint ventures involving physicians, health systems and ASC management companies represent one of the most attractive growth categories. These facilities combine physician alignment with professional operational management and frequently develop around high-value specialties such as orthopedics and spine.

Equipment decisions are typically based on standardized design templates, negotiated national contracts and lifecycle economics, creating opportunities for manufacturers capable of enterprise pricing and multiyear service agreements.

Corporate and Multisite ASC Networks

Large ASC operators increasingly influence national equipment procurement. Their scale allows centralized vendor negotiations, fleet standardization, preventive-maintenance contracts and lifecycle replacement programs. Manufacturers that can support consistent equipment configurations across many states can gain disproportionate share.

 

By Procurement Model

New Equipment

New equipment represents the largest revenue segment and will gain share through 2035. New-build facilities, high-acuity centers and hospital-affiliated ASCs prefer current-generation machines because of warranty coverage, advanced ventilation, connectivity, cybersecurity support and longer remaining useful life.

Refurbished and Pre-Owned Equipment

The refurbished segment remains structurally important in U.S. ambulatory surgery. Professionally refurbished GE and Dräger platforms are widely considered when facilities need proven equipment at a materially lower upfront cost. Demand is strongest among independent, single-specialty and startup ASCs.

The segment will remain resilient because the ASC value proposition itself is built around lower-cost care. However, older equipment increasingly faces limitations related to replacement parts, obsolete operating systems, unsupported monitoring modules and integration requirements.

Leasing, Financing and Managed Equipment Programs

Financing is expected to gain importance as higher-specification machines increase capital requirements. Leasing and managed-equipment arrangements allow facilities to align payments with procedure revenue, preserve cash and establish predictable refresh cycles. Multisite ASC operators may increasingly use enterprise arrangements that combine machines, preventive maintenance, accessories and replacement schedules.

 

Regional Insights: Where the Market Is Growing Fastest

The U.S. Ambulatory Surgery Center Anesthesia Machines Market is geographically segmented into the South, West, Northeast and Midwest. Geographic demand is driven less by total population alone than by the number of ASCs, specialty mix, physician entrepreneurship, certificate-of-need regulations, payer economics, population growth, procedure migration and the rate of new facility development.

Using March 2025 CMS-derived state facility counts, the 50 states and District of Columbia collectively accounted for approximately 6,434 Medicare-certified ASCs. Aggregating those state counts by Census-style regions indicates roughly 2,660 facilities in the South, 1,847 in the West, 1,083 in the Midwest and 844 in the Northeast. These regional totals are calculated from the published state-level facility data and illustrate why the South and West command a disproportionate share of ASC equipment opportunity.

South

The South is the largest regional market, representing an estimated USD 0.13 billion in ASC anesthesia-machine revenue in 2025. The region includes Delaware, Maryland, Virginia, West Virginia, North Carolina, South Carolina, Georgia, Florida, Kentucky, Tennessee, Mississippi, Alabama, Oklahoma, Texas, Arkansas and Louisiana, along with the District of Columbia.

The South’s leadership reflects both facility density and favorable demographic trends. Based on March 2025 CMS-derived data, the region contained approximately 2,660 Medicare-certified ASCs, more than 40% of the 50-state-and-DC total calculated from the published dataset.

Florida is one of the country’s most important ASC anesthesia-equipment markets, with approximately 517 Medicare-certified centers in the March 2025 dataset. The combination of an older population, high elective procedure volume, orthopedic demand, cataract surgery, GI procedures and continued healthcare construction supports both replacement and new-machine purchases. Florida also has a large base of independent and physician-invested centers, making value-oriented equipment and professionally refurbished systems commercially relevant.

Texas contained approximately 497 Medicare-certified ASCs, supported by major healthcare markets in Dallas-Fort Worth, Houston, Austin and San Antonio as well as rapid suburban population growth. Texas is particularly attractive for anesthesia-machine suppliers because of its large orthopedic, spine, pain, GI, ENT and multispecialty ASC ecosystem. Facilities range from cost-sensitive independent centers to sophisticated joint ventures capable of purchasing advanced electronic workstations.

Georgia is another unusually dense market with approximately 423 centers, giving the state one of the highest ASC counts in the country. Atlanta is the primary premium-technology cluster, while secondary metropolitan markets support demand for compact and economically configured anesthesia platforms.

Maryland, with approximately 347 centers, has a large ASC footprint relative to its population. Equipment purchasing is influenced by dense specialist networks, hospital affiliation and the state’s distinct healthcare regulatory environment. Multispecialty centers around the Baltimore-Washington corridor create opportunities for higher-capability systems.

North Carolina and Tennessee, with approximately 152 and 156 Medicare-certified centers respectively, benefit from population growth, strong orthopedic practices and increasing health-system participation in ambulatory surgery. Charlotte, Raleigh-Durham, Nashville, Knoxville and Memphis are important anesthesia-equipment demand clusters.

South Carolina, Alabama, Mississippi, Louisiana, Arkansas, Oklahoma, Kentucky, Virginia and West Virginia form smaller individual markets but collectively create substantial replacement demand. Rural access and lower facility density in some of these states increase the importance of durable machines, straightforward maintenance and dependable service coverage.

The South is projected to remain the largest market through 2035, reaching approximately USD 0.30 billion. Growth will be driven by greenfield ASC construction, orthopedic and spine migration, health-system joint ventures, expanding suburban populations and fleet replacement.

West

The West is expected to be the fastest-growing regional market, increasing from an estimated USD 0.08 billion in 2025 to approximately USD 0.19 billion by 2035. The region includes California, Washington, Oregon, Nevada, Arizona, Idaho, Utah, Montana, Wyoming, Colorado, New Mexico, Alaska and Hawaii.

Approximately 1,847 Medicare-certified ASCs were represented across these states in the March 2025 dataset. The regional market combines the enormous California installed base with rapidly expanding Sun Belt states.

California is the single most important state market in the country by facility count, with approximately 896 Medicare-certified ASCs in March 2025. The state supports nearly every ASC specialty, including orthopedics, GI, ophthalmology, ENT, plastic surgery, urology and multispecialty procedures. Los Angeles, Orange County, San Diego, the Bay Area and Sacramento create multiple large procurement clusters.

California’s commercial characteristics are distinct. High construction and labor costs increase pressure on OR productivity, while sophisticated anesthesia groups can support adoption of electronic workstations, low-flow technologies and digital documentation. Environmental priorities may also strengthen the business case for reducing volatile anesthetic consumption.

Arizona is one of the strongest emerging markets, with approximately 239 centers. Rapid population growth, retirement migration and expanding Phoenix-area medical infrastructure support rising joint replacement, spine, ophthalmology and GI volumes. New-build facilities create attractive demand for current-generation compact workstations.

Washington, with approximately 171 centers, has a sophisticated health-system and multispecialty ASC base. Seattle-area organizations tend to value digital integration, standardized monitoring and clinically advanced equipment, while facilities outside major metros place greater emphasis on service accessibility and reliability.

Colorado, with approximately 132 centers, benefits from a commercially attractive ambulatory surgery environment and strong orthopedic utilization. Denver and surrounding population corridors are particularly relevant for multispecialty and physician-led center development.

Oregon, Nevada and Utah each provide meaningful demand, while Idaho, Montana, Wyoming, New Mexico, Alaska and Hawaii are smaller installed-base markets. In these geographically dispersed states, service availability can become a decisive procurement factor because extended downtime may force case cancellations or hospital transfers.

The West is expected to gain market share through 2035 as Arizona, Nevada, Utah, Idaho and other growth states add outpatient surgical capacity while California maintains a large replacement cycle. The region’s modeled growth rate is above the national average.

Northeast

The Northeast represented an estimated USD 0.06 billion market in 2025 and is projected to reach approximately USD 0.13 billion by 2035. The region includes New York, New Jersey, Pennsylvania, Massachusetts, Connecticut, Rhode Island, Maine, New Hampshire and Vermont.

The March 2025 facility dataset indicates approximately 844 Medicare-certified ASCs across these states. Although the regional center count is lower than in the South and West, anesthesia-equipment spending per facility can be attractive because of dense specialist networks, complex procedure mix and hospital-system participation.

New Jersey is the largest Northeast ASC market by facility count, with approximately 250 Medicare-certified centers. Dense population, high specialist concentration and access to large commercially insured populations support GI, orthopedic, ophthalmic and multispecialty surgery.

Pennsylvania follows with approximately 239 centers, generating substantial demand across Philadelphia, Pittsburgh and regional healthcare markets. The state combines large health systems with independent surgical facilities, producing opportunities for both premium new equipment and refurbished machines.

New York had approximately 182 Medicare-certified centers. New York’s ASC penetration is lower relative to its population than several Sun Belt states, but the equipment market is supported by high case values, sophisticated specialty practices and continuing outpatient development around New York City and major upstate markets.

Massachusetts and Connecticut had approximately 58 and 54 centers respectively in the March 2025 dataset. These states have mature hospital ecosystems and high clinical standards, favoring advanced workstations, robust service support and integration with enterprise perioperative systems.

New Hampshire, Rhode Island, Maine and Vermont constitute smaller markets. Vermont had only a very small Medicare-certified ASC footprint in the cited dataset, demonstrating the significant geographic variation in U.S. ambulatory surgical infrastructure.

Northeast growth will be steady rather than explosive. Regulatory barriers, mature population growth and hospital concentration can constrain greenfield facility formation, but replacement demand and migration of progressively more complex cases should sustain attractive equipment spending.

Midwest

The Midwest accounted for an estimated USD 0.05 billion in 2025 and is projected to approach approximately USD 0.10 billion by 2035. The region includes Illinois, Indiana, Michigan, Ohio, Wisconsin, Minnesota, Iowa, Missouri, Kansas, Nebraska, North Dakota and South Dakota.

Approximately 1,083 Medicare-certified ASCs were represented across these states in March 2025. The Midwest is a mature but durable equipment market characterized by major academic systems, large community-hospital networks and established orthopedic and ophthalmology practices.

Ohio had approximately 210 Medicare-certified ASCs, the largest state footprint in the region. Cleveland, Columbus and Cincinnati support extensive surgical networks, while community markets create recurring replacement demand.

Indiana and Illinois contained approximately 140 and 136 centers respectively. Chicago is the region’s largest high-value medical market, but suburban and downstate facilities also support substantial ASC volume. Indiana has an established physician-owned and specialty surgery environment that is commercially attractive for compact and mid-tier workstations.

Michigan had approximately 126 centers, supported by Detroit-area health systems, orthopedic groups and large specialty practices. Minnesota, with approximately 92 centers, is strategically important despite its smaller population because of its sophisticated medical-device ecosystem and high standards for equipment evaluation.

Wisconsin, Missouri, Kansas and Nebraska provide stable installed-base demand, while Iowa, North Dakota and South Dakota are smaller markets where equipment durability and service reach can outweigh the value of advanced optional features.

The Midwest is expected to grow below the national average because facility expansion and population growth are less aggressive than in the South and West. Nevertheless, its large replacement base, orthopedic procedure volumes and mature provider infrastructure make the region a dependable revenue source through 2035.

 

Key Market Players

The competitive structure of the U.S. ASC anesthesia-machine market is more concentrated than the broader perioperative-device industry. GE HealthCare, Dräger, Mindray and Getinge represent the most visible full-workstation competitors in the U.S. clinical market, while a broader ecosystem of equipment manufacturers, refurbishers, patient-monitoring companies and anesthesia-support suppliers influences bundled ASC procurement.

Relevant participants in the U.S. competitive ecosystem include:

GE HealthCare
Drägerwerk AG & Co. KGaA / Dräger, Inc.
Mindray North America
Getinge AB
Penlon Limited
Beijing Aeonmed Co., Ltd.
Shenzhen Comen Medical Instruments Co., Ltd.
Shenzhen Prunus Medical Co., Ltd.
Infinium Medical
Avante Health Solutions
Soma Tech Intl
USOC Medical
Masimo Corporation
Nihon Kohden America
Philips
Medtronic
Teleflex Incorporated
Ambu A/S
Cardinal Health
Medline Industries
B. Braun Medical
ICU Medical
BD
Intersurgical

Core anesthesia workstation competition is led by platforms from GE HealthCare, Dräger, Mindray and Getinge. GE HealthCare offers systems ranging from compact Carestation configurations to higher-end Aisys and Carestation platforms. Its U.S. product portfolio emphasizes integrated anesthesia delivery, low-flow performance, ventilation and data connectivity.

Dräger maintains a strong U.S. anesthesia presence through systems including the Atlan and Perseus families and has a significant legacy installed base. Its piston-ventilation architecture and longstanding anesthesia specialization provide strong brand recognition among anesthesia departments.

Getinge competes through the Flow family, including the Flow-c compact model specifically positioned for busy ASC environments. Its emphasis on electronic gas control, low-flow operation and advanced ventilation provides differentiation in multispecialty and higher-acuity surgery centers.

Mindray competes primarily on the combination of digital functionality, monitoring integration and acquisition economics. Its A-series anesthesia platforms include advanced gas monitoring and low-flow decision-support functionality, positioning the company as an important challenger when facilities compare functionality per capital dollar.

The refurbished equipment channel is unusually important in this market. Avante Health Solutions, Soma Tech Intl, USOC Medical and other specialty equipment organizations extend the usable commercial life of established anesthesia platforms by refurbishing systems, replacing components, providing vaporizers and supporting service. This channel exerts pricing pressure on new-machine manufacturers because ASC administrators can directly compare a new digital workstation with a substantially less expensive refurbished legacy platform.

Competitive share through 2035 will increasingly depend on the ability to demonstrate total cost of ownership rather than acquisition price alone. Manufacturers with reliable field service, favorable preventive-maintenance requirements, strong parts availability, clinically intuitive interfaces and scalable configurations will be advantaged. Multisite networks will also favor vendors capable of standardized fleet deployment, enterprise contracting and predictable replacement schedules.

 

Recent Developments

One of the most consequential recent developments for the addressable market occurred in November 2025, when CMS finalized major changes to outpatient and ASC policy for calendar year 2026. The agency added 289 procedures to the ASC Covered Procedures List and another 271 codes associated with procedures removed from the inpatient-only list. The policy significantly increases the future range of procedures that physicians may evaluate for outpatient settings when clinically appropriate.

The development is important for anesthesia-machine suppliers because procedure migration increasingly involves cases requiring more sophisticated ventilation, anesthetic delivery and postoperative planning. The commercial opportunity will not come from every newly eligible code. It will come from the subset of procedures for which ASC operators can build repeatable, financially attractive clinical pathways.

CMS’s July 2026 proposed rule for calendar year 2027 further demonstrates the policy momentum toward outpatient care. The proposal would affect approximately 6,400 ASCs and proposes a 2.4% ASC payment-rate update for facilities meeting applicable quality-reporting requirements. Because this remained a proposed rule as of August 2026, it should be treated as a forward policy indicator rather than a finalized reimbursement assumption.

Equipment safety has also remained highly visible. In June 2026, the FDA classified a correction involving certain Dräger Atlan A350 and A350XL anesthesia workstations as the most serious type of recall after an issue involving possible mechanical ventilation failure. The correction involved specified affected devices and, according to FDA information available at that time, no reported injuries or deaths.

The event illustrates an important procurement reality: anesthesia machines are life-support systems, and ASC buyers must evaluate supplier quality systems, corrective-action responsiveness, field-service capability and backup planning alongside price and functionality.

Technology development continues to emphasize low-flow anesthesia, automated gas delivery, advanced ventilation and compact machine design. GE HealthCare’s U.S. anesthesia portfolio includes automated end-tidal control capabilities on its Aisys platform, while Getinge’s Flow family incorporates automated gas-control and hypoxia-prevention functions.

Another important market development is the strengthening of the secondary-equipment channel. As new platforms become more digitally sophisticated and expensive, legacy GE and Dräger machines continue to circulate through professional refurbishment. This gives ASC operators more procurement flexibility but simultaneously raises questions around software support, component availability, service expertise and remaining useful life.

Over the next several years, the competitive battleground is therefore expected to shift toward platform lifecycle management. Winning suppliers will increasingly combine the workstation with preventive maintenance, remote support, training, vaporizers, breathing-system accessories, connectivity and scheduled technology refresh rather than treating each machine as a one-time capital sale.

 

Conclusion

The U.S. Ambulatory Surgery Center Anesthesia Machines Market Size & Share is positioned for sustained expansion from approximately USD 0.32 billion in 2025 to USD 0.72 billion by 2035, representing an 8.45% CAGR during 2026–2035.

The underlying growth thesis is stronger than simple replacement demand. The United States has developed an ASC infrastructure exceeding 6,500 Medicare-certified facilities and more than 23 million outpatient procedures annually. Policy changes are expanding the procedural frontier, health systems are increasingly partnering with physicians to develop ambulatory facilities, and orthopedic, spine and other higher-complexity cases are raising anesthesia requirements.

This evolution changes the economics of anesthesia equipment. A machine can no longer be evaluated only on acquisition price. The key commercial measures are cost per usable operating-room year, downtime risk, daily checkout burden, anesthetic-agent consumption, ventilation capability, room footprint, user familiarity, electronic documentation, service response and ability to support future case-mix expansion.

Integrated digital workstations will generate the largest share of value, while compact anesthesia machines and low-flow or automated gas-control technologies should record above-market growth. Orthopedic and spine ASCs represent the most important incremental procedure opportunity because of their anesthesia intensity and stronger capital economics. Gastroenterology and ophthalmology will remain high-volume installed-base markets, while ENT, urology, gynecology and general surgery will contribute to diversification of multispecialty centers.

From a procurement perspective, the market will remain bifurcated. Sophisticated health-system and joint-venture centers will increasingly adopt current-generation electronic systems with advanced ventilation, connectivity and stronger lifecycle support. Independent facilities will continue to create meaningful demand for value-configured and professionally refurbished machines. Vendors must therefore compete across both technology and economic flexibility.

Regionally, the South is expected to remain the largest market, supported by approximately 2,660 Medicare-certified ASCs across the region in the March 2025 state-level dataset, rapid population growth and dense facility networks in Florida, Texas, Georgia and Maryland. The West is expected to grow fastest, led by California’s exceptionally large installed base and expansion in Arizona, Colorado, Nevada, Utah and other high-growth states. The Northeast will remain a high-value but more mature equipment market, while the Midwest will provide stable replacement and specialty-surgery demand.

California, Florida and Texas will remain particularly important commercial targets. The March 2025 dataset recorded approximately 896 Medicare-certified ASCs in California, 517 in Florida and 497 in Texas, giving these three states alone a very large share of the national installed-base opportunity. Georgia, Maryland, New Jersey, Arizona, Pennsylvania, Ohio, New York, Washington, Tennessee and North Carolina form a second tier of strategically important state markets.

For manufacturers, investors, ASC developers, distributors and healthcare strategists, the most important question through 2035 is not simply how many anesthesia machines U.S. surgery centers will purchase. The more important questions are which procedures will migrate fastest, which facilities will require higher-acuity capabilities, how quickly installed fleets will be replaced, where new ASC construction will concentrate, and which workstation architectures can produce measurable operating-room efficiency without imposing hospital-level capital and maintenance costs.

The companies best positioned to gain share will be those that align clinical sophistication with the fundamental economics of ambulatory surgery: reliable equipment, efficient workflows, rapid patient recovery, low operating cost and dependable support across a growing national network of outpatient operating rooms.

 

TABLE OF CONTENT

1. U.S. Ambulatory Surgery Center Anesthesia Machines Market: Market Introduction & Context

1.1. Market Definition
1.2. Scope of the Study
1.3. Research Methodology
1.3.1. Primary Data Collection
1.3.2. Secondary Data Sourcing
1.3.3. External Industry Collaborations
1.3.4. In-House Research Databases
1.3.5. Bottom-Up ASC Installed-Base Assessment
1.3.6. Top-Down Market Sizing & Triangulation
1.3.7. Analytical Frameworks & Forecasting Models
1.3.8. Data Validation and Final Report Publishing
1.4. Key Assumptions
1.5. Market Ecosystem Overview
1.6. Stakeholder Analysis
1.6.1. Anesthesia Machine and Workstation Manufacturers
1.6.2. Vaporizers, Ventilation and Gas Delivery Component Suppliers
1.6.3. Independent and Physician-Owned Ambulatory Surgery Centers
1.6.4. Hospital and Health-System-Affiliated ASCs
1.6.5. Joint-Venture and Corporate Multisite ASC Operators
1.6.6. Anesthesiology Groups, CRNA Practices and Perioperative Service Providers
1.6.7. Medical Equipment Refurbishers and Specialty Dealers
1.6.8. Group Purchasing Organizations and Distributors
1.6.9. CMS, FDA, Accreditation Bodies and State Regulators
What this section provides: This section defines the market boundary, research methodology, sizing assumptions, ASC-specific equipment ecosystem, and stakeholder groups so clients understand how the U.S. ambulatory surgery center anesthesia machines market is measured, validated, and forecast.

2. U.S. Ambulatory Surgery Center Anesthesia Machines Market: Executive Summary

2.1. Key Insights & Market Snapshot
2.2. Analyst Viewpoint
2.3. Market Attractiveness Index
2.4. Historical Market Summary, 2021–2024
2.5. Base Year Market Positioning, 2025
2.6. Forecast Outlook, 2026–2035
2.7. Market Size & CAGR Snapshot, 2025–2035
2.8. ASC Installed-Base and Operating-Room Opportunity Assessment
2.9. High-Growth Opportunity Areas
2.10. High-Priority States and ASC Procedure Hubs
What this section provides: This section gives decision-makers an executive view of market size, CAGR, installed-base opportunity, equipment replacement requirements, regional growth pockets, procedural demand, competitive intensity, and the most attractive investment areas through 2035.

3. U.S. Ambulatory Surgery Center Anesthesia Machines Market: Market Dynamics & Outlook

3.1. Drivers and Their Impact Analysis
3.1.1. Expansion of Medicare-Certified Ambulatory Surgery Centers
3.1.2. Accelerating Migration of Procedures from Hospitals to ASCs
3.1.3. Growth of Outpatient Orthopedic and Total Joint Procedures
3.1.4. Expansion of Spine, ENT, Urology and Multispecialty ASC Case Mix
3.1.5. Rising Complexity of Patients Treated in Ambulatory Settings
3.1.6. Aging Installed Base of ASC Anesthesia Machines
3.1.7. Adoption of Compact Digital Anesthesia Workstations
3.1.8. Demand for Low-Flow Anesthesia and Reduced Volatile Agent Consumption
3.1.9. Growth of Health-System and Physician Joint-Venture ASCs
3.1.10. ASC Operating-Room Throughput and Turnover Optimization
3.2. Restraints and Their Impact Analysis
3.2.1. High Capital Cost of Advanced Anesthesia Workstations
3.2.2. Strong Price Sensitivity Among Independent ASCs
3.2.3. Limited Anesthesia Machine Utilization in Sedation-Heavy Specialties
3.2.4. Availability of Refurbished and Legacy Anesthesia Systems
3.2.5. Reimbursement and Site-of-Service Uncertainty
3.2.6. Equipment Maintenance and Biomedical Engineering Constraints
3.3. Opportunities and Their Impact Analysis
3.3.1. Orthopedic and Total Joint ASC Expansion
3.3.2. Outpatient Spine Procedure Migration
3.3.3. Compact and Space-Efficient Anesthesia Workstations
3.3.4. Low-Flow and Automated Gas-Control Technologies
3.3.5. Connected Anesthesia Machines and Digital Documentation
3.3.6. Enterprise Fleet Standardization Across Multisite ASC Networks
3.3.7. Refurbishment, Leasing and Managed Equipment Programs
3.3.8. Replacement of Unsupported Legacy Platforms
3.4. Challenges and Their Impact Analysis
3.4.1. Anesthesia Workforce Availability
3.4.2. Product Recall and Patient-Safety Risk
3.4.3. Integration with Existing Patient Monitoring Infrastructure
3.4.4. Service Coverage and Equipment Downtime
3.4.5. Cybersecurity and Software Support
3.4.6. ASC Capital Budget Prioritization
3.5. Patent & Innovation Analysis, 2021–2025
3.6. ASC Clinical Workflow Economics Analysis
3.7. Anesthesia Machine Total Cost of Ownership Analysis
3.8. ASC Operating-Room Turnover and Equipment Utilization Analysis
3.9. ASC Capital Procurement Behavior Analysis
3.10. New-Build Versus Replacement Demand Analysis
What this section provides: This section explains the clinical, operational, reimbursement, technological and economic forces determining ASC anesthesia-machine purchasing and helps clients assess market upside, adoption barriers, replacement cycles and execution risk.

4. U.S. Ambulatory Surgery Center Anesthesia Machines Market: Market Environment & Industry Analysis

4.1. PESTEL Analysis
4.1.1. Political
4.1.2. Economic
4.1.3. Social
4.1.4. Technological
4.1.5. Environmental
4.1.6. Legal
4.2. Porter’s Five Forces Analysis
4.2.1. Threat of New Entrants
4.2.2. Bargaining Power of ASC Buyers
4.2.3. Bargaining Power of Suppliers
4.2.4. Substitution Risk from Refurbished and Legacy Equipment
4.2.5. Competitive Rivalry
4.3. Anesthesia Machine Pricing Trend Analysis by Region, 2025–2035
4.4. Value Chain & Supply Chain Analysis
4.5. OEM, Distributor and Refurbisher Channel Analysis
4.6. Impact of Digitalization on ASC Anesthesia Delivery
4.7. Application & Innovation Landscape
4.8. FDA Regulatory Framework Analysis
4.9. CMS ASC Coverage and Reimbursement Landscape
4.10. ASC Accreditation, Certification and State Licensing Landscape
4.11. Anesthesia Machine Safety, Maintenance and Recall Landscape
4.12. Environmental Impact of Inhaled Anesthetics and Low-Flow Adoption
4.13. Import/Export Restrictions & Tariff Impact
4.14. Supply-Chain and Component Availability Analysis
4.15. Impact of Escalating Geopolitical Tensions
4.16. ASC Capital Equipment Decision-Making Framework
4.17. Group Purchasing and Enterprise Contracting Dynamics
What this section provides: This section gives clients a complete view of regulation, reimbursement, accreditation, pricing, supply chains, environmental considerations, technology adoption and ASC capital-equipment procurement dynamics affecting anesthesia-machine commercialization.

5. U.S. Ambulatory Surgery Center Anesthesia Machines Market – By Product Type

5.1. Overview
5.1.1. Segment Share Analysis, By Product Type, 2025 & 2035 (%)
5.1.2. Integrated Anesthesia Workstations
5.1.3. Compact Anesthesia Machines
5.1.4. Portable and Mobile Anesthesia Machines
5.1.5. Modular and Standalone Anesthesia Systems
5.1.6. Advanced High-Acuity Anesthesia Workstations
What this section provides: This section identifies which anesthesia-machine configurations generate the strongest ASC revenue contribution and evaluates how room size, procedure complexity, patient acuity and capital budgets influence product selection through 2035.

6. U.S. Ambulatory Surgery Center Anesthesia Machines Market – By Technology

6.1. Overview
6.1.1. Segment Share Analysis, By Technology, 2025 & 2035 (%)
6.1.2. Electronic and Digitally Controlled Anesthesia Systems
6.1.3. Conventional Pneumatic and Mechanically Controlled Systems
6.1.4. Low-Flow and Closed/Semi-Closed Circuit Systems
6.1.5. Automated Gas-Control Anesthesia Systems
6.1.6. Connectivity-Enabled and Smart Anesthesia Workstations
What this section provides: This section evaluates the technology transition from conventional anesthesia platforms toward digital gas delivery, low-flow operation, automation and connected perioperative workflows.

7. U.S. Ambulatory Surgery Center Anesthesia Machines Market – By Surgical Specialty

7.1. Overview
7.1.1. Segment Share Analysis, By Surgical Specialty, 2025 & 2035 (%)
7.1.2. Orthopedic and Total Joint Surgery
7.1.3. Spine Surgery
7.1.4. Gastroenterology and Advanced Endoscopy
7.1.5. Ophthalmology
7.1.6. ENT and Oral/Maxillofacial Surgery
7.1.7. Urology and Gynecology
7.1.8. General Surgery
7.1.9. Plastic and Reconstructive Surgery
7.1.10. Other Ambulatory Surgical Specialties
What this section provides: This section identifies surgical specialties generating the highest anesthesia-machine utilization and highlights procedure categories where outpatient migration, general-anesthesia intensity and ASC case complexity create the strongest equipment opportunity.

8. U.S. Ambulatory Surgery Center Anesthesia Machines Market – By Facility Model

8.1. Overview
8.1.1. Segment Share Analysis, By Facility Model, 2025 & 2035 (%)
8.1.2. Independent and Physician-Owned ASCs
8.1.3. Hospital and Health-System-Affiliated ASCs
8.1.4. Physician–Hospital Joint-Venture ASCs
8.1.5. Corporate and Multisite ASC Networks
8.1.6. Specialty-Specific and Multispecialty ASCs
What this section provides: This section explains how ownership structure, physician alignment, enterprise standardization, case mix and capital availability influence anesthesia-machine selection and purchasing behavior across different ASC facility models.

9. U.S. Ambulatory Surgery Center Anesthesia Machines Market – By Procurement Model

9.1. Overview
9.1.1. Segment Share Analysis, By Procurement Model, 2025 & 2035 (%)
9.1.2. New Equipment Purchases
9.1.3. Refurbished and Pre-Owned Equipment Purchases
9.1.4. Leasing and Equipment Financing
9.1.5. Managed Equipment and Service-Bundled Programs
9.1.6. Enterprise, GPO and Multisite Procurement Contracts
What this section provides: This section analyzes how U.S. ASCs finance and acquire anesthesia machines and evaluates the competitive implications of new equipment, refurbished platforms, leasing, bundled service models and enterprise contracting.

10. U.S. Ambulatory Surgery Center Anesthesia Machines Market – By Geography

10.1. Introduction
10.1.1. Segment Share Analysis, By Geography, 2025 & 2035 (%)
10.1.2. Regional Market Size and Forecast, 2021–2035 (US$ Billion)
10.1.3. Regional ASC Installed-Base Analysis
10.1.4. Regional ASC Procedure Volume and Surgical Specialty Mix
10.1.5. Regional New-Build and Replacement Equipment Opportunity
10.1.6. Regional Reimbursement, Regulatory and Procurement Dynamics
10.2. West Region
10.2.1. Regional Overview & Trends
10.2.2. West Region Key Anesthesia Machine Manufacturers and Procurement Ecosystem
10.2.3. West Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.2.4. West Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.5. West Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.6. West Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.7. West Region Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.8. West Region Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.9. California
10.2.9.1. Overview
10.2.9.2. California Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.9.3. California Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.9.4. California Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.9.5. California Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.9.6. California Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.10. Washington
10.2.10.1. Overview
10.2.10.2. Washington Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.10.3. Washington Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.10.4. Washington Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.10.5. Washington Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.10.6. Washington Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.11. Arizona
10.2.11.1. Overview
10.2.11.2. Arizona Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.11.3. Arizona Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.11.4. Arizona Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.11.5. Arizona Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.11.6. Arizona Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.12. Colorado
10.2.12.1. Overview
10.2.12.2. Colorado Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.12.3. Colorado Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.12.4. Colorado Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.12.5. Colorado Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.12.6. Colorado Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.13. Oregon
10.2.13.1. Overview
10.2.13.2. Oregon Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.13.3. Oregon Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.13.4. Oregon Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.13.5. Oregon Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.13.6. Oregon Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.14. Utah
10.2.14.1. Overview
10.2.14.2. Utah Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.14.3. Utah Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.14.4. Utah Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.14.5. Utah Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.14.6. Utah Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.15. Nevada
10.2.15.1. Overview
10.2.15.2. Nevada Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.15.3. Nevada Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.15.4. Nevada Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.15.5. Nevada Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.15.6. Nevada Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.16. New Mexico
10.2.16.1. Overview
10.2.16.2. New Mexico Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.16.3. New Mexico Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.16.4. New Mexico Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.16.5. New Mexico Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.16.6. New Mexico Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.17. Idaho
10.2.17.1. Overview
10.2.17.2. Idaho Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.17.3. Idaho Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.17.4. Idaho Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.17.5. Idaho Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.17.6. Idaho Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.18. Montana
10.2.18.1. Overview
10.2.18.2. Montana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.18.3. Montana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.18.4. Montana Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.18.5. Montana Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.18.6. Montana Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.19. Wyoming
10.2.19.1. Overview
10.2.19.2. Wyoming Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.19.3. Wyoming Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.19.4. Wyoming Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.19.5. Wyoming Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.19.6. Wyoming Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.20. Alaska
10.2.20.1. Overview
10.2.20.2. Alaska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.20.3. Alaska Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.20.4. Alaska Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.20.5. Alaska Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.20.6. Alaska Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.2.21. Hawaii
10.2.21.1. Overview
10.2.21.2. Hawaii Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.2.21.3. Hawaii Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.2.21.4. Hawaii Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.2.21.5. Hawaii Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.2.21.6. Hawaii Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3. Northeast Region
10.3.1. Regional Overview & Trends
10.3.2. Northeast Region Key Anesthesia Machine Manufacturers and Procurement Ecosystem
10.3.3. Northeast Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.3.4. Northeast Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.5. Northeast Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.6. Northeast Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.7. Northeast Region Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.8. Northeast Region Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.9. New York
10.3.9.1. Overview
10.3.9.2. New York Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.9.3. New York Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.9.4. New York Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.9.5. New York Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.9.6. New York Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.10. Massachusetts
10.3.10.1. Overview
10.3.10.2. Massachusetts Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.10.3. Massachusetts Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.10.4. Massachusetts Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.10.5. Massachusetts Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.10.6. Massachusetts Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.11. New Jersey
10.3.11.1. Overview
10.3.11.2. New Jersey Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.11.3. New Jersey Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.11.4. New Jersey Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.11.5. New Jersey Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.11.6. New Jersey Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.12. Pennsylvania
10.3.12.1. Overview
10.3.12.2. Pennsylvania Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.12.3. Pennsylvania Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.12.4. Pennsylvania Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.12.5. Pennsylvania Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.12.6. Pennsylvania Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.13. Connecticut
10.3.13.1. Overview
10.3.13.2. Connecticut Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.13.3. Connecticut Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.13.4. Connecticut Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.13.5. Connecticut Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.13.6. Connecticut Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.14. Maine
10.3.14.1. Overview
10.3.14.2. Maine Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.14.3. Maine Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.14.4. Maine Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.14.5. Maine Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.14.6. Maine Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.15. Vermont
10.3.15.1. Overview
10.3.15.2. Vermont Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.15.3. Vermont Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.15.4. Vermont Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.15.5. Vermont Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.15.6. Vermont Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.16. New Hampshire
10.3.16.1. Overview
10.3.16.2. New Hampshire Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.16.3. New Hampshire Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.16.4. New Hampshire Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.16.5. New Hampshire Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.16.6. New Hampshire Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.17. Rhode Island
10.3.17.1. Overview
10.3.17.2. Rhode Island Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.17.3. Rhode Island Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.17.4. Rhode Island Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.17.5. Rhode Island Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.17.6. Rhode Island Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.3.18. Delaware
10.3.18.1. Overview
10.3.18.2. Delaware Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.3.18.3. Delaware Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.3.18.4. Delaware Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.3.18.5. Delaware Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.3.18.6. Delaware Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4. South Region
10.4.1. Regional Overview & Trends
10.4.2. South Region Key Anesthesia Machine Manufacturers and Procurement Ecosystem
10.4.3. South Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.4.4. South Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.5. South Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.6. South Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.7. South Region Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.8. South Region Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.9. Texas
10.4.9.1. Overview
10.4.9.2. Texas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.9.3. Texas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.9.4. Texas Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.9.5. Texas Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.9.6. Texas Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.10. Florida
10.4.10.1. Overview
10.4.10.2. Florida Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.10.3. Florida Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.10.4. Florida Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.10.5. Florida Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.10.6. Florida Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.11. Georgia
10.4.11.1. Overview
10.4.11.2. Georgia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.11.3. Georgia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.11.4. Georgia Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.11.5. Georgia Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.11.6. Georgia Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.12. North Carolina
10.4.12.1. Overview
10.4.12.2. North Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.12.3. North Carolina Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.12.4. North Carolina Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.12.5. North Carolina Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.12.6. North Carolina Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.13. Tennessee
10.4.13.1. Overview
10.4.13.2. Tennessee Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.13.3. Tennessee Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.13.4. Tennessee Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.13.5. Tennessee Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.13.6. Tennessee Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.14. South Carolina
10.4.14.1. Overview
10.4.14.2. South Carolina Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.14.3. South Carolina Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.14.4. South Carolina Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.14.5. South Carolina Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.14.6. South Carolina Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.15. Alabama
10.4.15.1. Overview
10.4.15.2. Alabama Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.15.3. Alabama Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.15.4. Alabama Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.15.5. Alabama Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.15.6. Alabama Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.16. Mississippi
10.4.16.1. Overview
10.4.16.2. Mississippi Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.16.3. Mississippi Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.16.4. Mississippi Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.16.5. Mississippi Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.16.6. Mississippi Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.17. Louisiana
10.4.17.1. Overview
10.4.17.2. Louisiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.17.3. Louisiana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.17.4. Louisiana Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.17.5. Louisiana Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.17.6. Louisiana Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.18. Arkansas
10.4.18.1. Overview
10.4.18.2. Arkansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.18.3. Arkansas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.18.4. Arkansas Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.18.5. Arkansas Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.18.6. Arkansas Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.19. Kentucky
10.4.19.1. Overview
10.4.19.2. Kentucky Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.19.3. Kentucky Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.19.4. Kentucky Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.19.5. Kentucky Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.19.6. Kentucky Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.20. Oklahoma
10.4.20.1. Overview
10.4.20.2. Oklahoma Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.20.3. Oklahoma Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.20.4. Oklahoma Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.20.5. Oklahoma Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.20.6. Oklahoma Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.21. Virginia
10.4.21.1. Overview
10.4.21.2. Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.21.3. Virginia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.21.4. Virginia Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.21.5. Virginia Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.21.6. Virginia Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.22. Maryland
10.4.22.1. Overview
10.4.22.2. Maryland Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.22.3. Maryland Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.22.4. Maryland Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.22.5. Maryland Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.22.6. Maryland Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.4.23. West Virginia
10.4.23.1. Overview
10.4.23.2. West Virginia Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.4.23.3. West Virginia Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.4.23.4. West Virginia Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.4.23.5. West Virginia Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.4.23.6. West Virginia Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5. Midwest Region
10.5.1. Regional Overview & Trends
10.5.2. Midwest Region Key Anesthesia Machine Manufacturers and Procurement Ecosystem
10.5.3. Midwest Region Market Size and Forecast, By State, 2021–2035 (US$ Billion)
10.5.4. Midwest Region Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.5. Midwest Region Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.6. Midwest Region Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.7. Midwest Region Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.8. Midwest Region Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.9. Illinois
10.5.9.1. Overview
10.5.9.2. Illinois Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.9.3. Illinois Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.9.4. Illinois Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.9.5. Illinois Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.9.6. Illinois Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.10. Ohio
10.5.10.1. Overview
10.5.10.2. Ohio Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.10.3. Ohio Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.10.4. Ohio Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.10.5. Ohio Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.10.6. Ohio Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.11. Michigan
10.5.11.1. Overview
10.5.11.2. Michigan Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.11.3. Michigan Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.11.4. Michigan Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.11.5. Michigan Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.11.6. Michigan Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.12. Minnesota
10.5.12.1. Overview
10.5.12.2. Minnesota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.12.3. Minnesota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.12.4. Minnesota Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.12.5. Minnesota Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.12.6. Minnesota Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.13. Indiana
10.5.13.1. Overview
10.5.13.2. Indiana Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.13.3. Indiana Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.13.4. Indiana Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.13.5. Indiana Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.13.6. Indiana Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.14. Wisconsin
10.5.14.1. Overview
10.5.14.2. Wisconsin Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.14.3. Wisconsin Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.14.4. Wisconsin Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.14.5. Wisconsin Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.14.6. Wisconsin Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.15. Missouri
10.5.15.1. Overview
10.5.15.2. Missouri Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.15.3. Missouri Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.15.4. Missouri Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.15.5. Missouri Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.15.6. Missouri Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.16. Iowa
10.5.16.1. Overview
10.5.16.2. Iowa Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.16.3. Iowa Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.16.4. Iowa Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.16.5. Iowa Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.16.6. Iowa Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.17. Kansas
10.5.17.1. Overview
10.5.17.2. Kansas Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.17.3. Kansas Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.17.4. Kansas Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.17.5. Kansas Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.17.6. Kansas Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.18. Nebraska
10.5.18.1. Overview
10.5.18.2. Nebraska Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.18.3. Nebraska Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.18.4. Nebraska Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.18.5. Nebraska Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.18.6. Nebraska Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.19. North Dakota
10.5.19.1. Overview
10.5.19.2. North Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.19.3. North Dakota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.19.4. North Dakota Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.19.5. North Dakota Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.19.6. North Dakota Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
10.5.20. South Dakota
10.5.20.1. Overview
10.5.20.2. South Dakota Market Size and Forecast, By Product Type, 2021–2035 (US$ Billion)
10.5.20.3. South Dakota Market Size and Forecast, By Technology, 2021–2035 (US$ Billion)
10.5.20.4. South Dakota Market Size and Forecast, By Surgical Specialty, 2021–2035 (US$ Billion)
10.5.20.5. South Dakota Market Size and Forecast, By Facility Model, 2021–2035 (US$ Billion)
10.5.20.6. South Dakota Market Size and Forecast, By Procurement Model, 2021–2035 (US$ Billion)
What this section provides: This section delivers detailed U.S. regional and state-level analysis, allowing clients to identify priority ASC markets, anesthesia-machine installed-base concentrations, procedure-volume hubs, new-facility opportunities, replacement hotspots and state-level commercial opportunities.

11. U.S. Ambulatory Surgery Center Anesthesia Machines Market: Competitive Landscape & Company Profiles

11.1. Market Share Analysis, 2025
11.2. Competitive Benchmarking Analysis
11.2.1. Product Breadth
11.2.2. ASC Suitability
11.2.3. Technology Sophistication
11.2.4. Price Positioning
11.2.5. Service & Maintenance Coverage
11.2.6. Distribution Reach
11.2.7. Refurbished Equipment Exposure
11.3. Company Positioning Matrix
11.3.1. Leaders
11.3.2. Challengers
11.3.3. Innovators
11.3.4. Value-Focused Players
11.3.5. Emerging Players
11.4. Company Profiles
11.4.1. GE HealthCare
11.4.2. Drägerwerk AG & Co. KGaA / Dräger, Inc.
11.4.3. Mindray North America
11.4.4. Getinge AB
11.4.5. Penlon Limited
11.4.6. Beijing Aeonmed Co., Ltd.
11.4.7. Shenzhen Comen Medical Instruments Co., Ltd.
11.4.8. Shenzhen Prunus Medical Co., Ltd.
11.4.9. Infinium Medical
11.4.10. Avante Health Solutions
11.4.11. Soma Tech Intl
11.4.12. USOC Medical
11.4.13. Masimo Corporation
11.4.14. Nihon Kohden America
11.4.15. Philips
11.4.16. Medtronic
11.4.17. Teleflex Incorporated
11.4.18. Ambu A/S
11.4.19. Cardinal Health
11.4.20. Medline Industries, LP
11.4.21. B. Braun Medical Inc.
11.4.22. ICU Medical, Inc.
11.4.23. BD
11.4.24. Intersurgical Inc.
Note: Each company profile will include company overview, anesthesia and perioperative product portfolio, U.S. ASC market positioning, technology strategy, pricing and service model, distribution footprint, regulatory developments, strategic partnerships, competitive strengths and recent developments.
What this section provides: This section gives clients competitor benchmarking, market-share visibility, anesthesia-workstation positioning, service and distribution intelligence, refurbished-equipment dynamics, innovation direction and strategic analysis of major companies influencing U.S. ASC anesthesia-equipment procurement.

12. U.S. Ambulatory Surgery Center Anesthesia Machines Market: Future Market Outlook, 2026–2035

12.1. Scenario Analysis
12.1.1. Optimistic Scenario
12.1.2. Realistic Scenario
12.1.3. Pessimistic Scenario
12.2. Disruptive Technologies Impact
12.2.1. Automated End-Tidal and Gas-Control Technologies
12.2.2. Low-Flow and Ultra-Low-Flow Anesthesia
12.2.3. Advanced Lung-Protective Ventilation
12.2.4. Smart and Connectivity-Enabled Anesthesia Workstations
12.2.5. AI-Assisted Anesthesia Decision Support
12.2.6. Automated Machine Checkout and Safety Monitoring
12.2.7. Remote Diagnostics and Predictive Maintenance
12.2.8. Digital Anesthesia Records and EMR Integration
12.3. Impact of Future ASC Procedure Migration
12.4. Future Anesthesia Machine Replacement Cycle
12.5. Emerging Business Trends
12.6. Business Opportunities for OEMs and Existing Players
12.7. Opportunities for Equipment Refurbishers and Service Providers
12.8. Investment Prioritization Matrix
12.9. High-Growth State Opportunity Matrix
What this section provides: This section prepares clients for future technology shifts, ASC case-mix expansion, equipment replacement cycles, market-structure changes, emerging business models and investment opportunities through 2035.

13. U.S. Ambulatory Surgery Center Anesthesia Machines Market: Strategic Recommendations

13.1. Recommendations for Anesthesia Machine Manufacturers
13.2. Recommendations for Independent and Physician-Owned ASCs
13.3. Recommendations for Hospital and Health-System-Affiliated ASCs
13.4. Recommendations for Corporate and Multisite ASC Operators
13.5. Recommendations for Investors and Private Equity Firms
13.6. Recommendations for Distributors and Channel Partners
13.7. Recommendations for Refurbished Equipment Providers
13.8. Recommendations for New Entrants and Emerging Players
13.9. U.S. Go-to-Market Strategy Considerations
13.10. Product Positioning and Portfolio Expansion Guidance
13.11. ASC Enterprise Contracting Strategy
13.12. Pricing, Financing and Service-Bundle Strategy
13.13. State-Level Commercial Prioritization Strategy
What this section provides: This section converts market intelligence into actionable recommendations for product development, ASC targeting, commercial expansion, pricing, enterprise contracting, service strategy, investment decisions and competitive differentiation.

14. U.S. Ambulatory Surgery Center Anesthesia Machines Market: Disclaimer

14.1. Scope Limitation
14.2. Data Use Limitation
14.3. Market Sizing Limitation
14.4. Forecasting Limitation
14.5. State-Level Estimate Limitation
14.6. Regulatory and Reimbursement Disclaimer
14.7. Legal Disclaimer
14.8. Third-Party Data Disclaimer
What this section provides: This section clarifies the report’s scope, methodological constraints, state-level estimation limitations, regulatory and reimbursement considerations, forecasting assumptions, legal boundaries and data-use terms.

 

List of Tables

TABLE 1: List of Data Sources
TABLE 2: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Market Definition and Scope
TABLE 3: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Research Methodology Framework
TABLE 4: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Key Assumptions
TABLE 5: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Market Ecosystem Overview
TABLE 6: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Stakeholder Analysis
TABLE 7: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Executive Summary Snapshot, 2025
TABLE 8: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Analyst Viewpoint Summary
TABLE 9: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Market Attractiveness Index
TABLE 10: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Historical Market Size, 2021–2024 (US$ Billion)
TABLE 11: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Forecast Market Size, 2026–2035 (US$ Billion)
TABLE 12: U.S. Ambulatory Surgery Center Anesthesia Machines Market: ASC Installed-Base and High-Growth Opportunity Snapshot
TABLE 13: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Drivers; Impact Analysis
TABLE 14: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Restraints; Impact Analysis
TABLE 15: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Opportunities; Impact Analysis
TABLE 16: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Challenges; Impact Analysis
TABLE 17: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Patent & Innovation Analysis, 2021–2025
TABLE 18: U.S. Ambulatory Surgery Center Anesthesia Machines Market: ASC Clinical Workflow Economics Matrix
TABLE 19: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Total Cost of Ownership Matrix
TABLE 20: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Operating-Room Turnover and Equipment Utilization Matrix
TABLE 21: U.S. Ambulatory Surgery Center Anesthesia Machines Market: ASC Capital Procurement Behavior Matrix
TABLE 22: U.S. Ambulatory Surgery Center Anesthesia Machines Market: New-Build vs. Replacement Demand Analysis
TABLE 23: U.S. Ambulatory Surgery Center Anesthesia Machines Market: PESTEL Analysis
TABLE 24: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Porter’s Five Forces Analysis
TABLE 25: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Pricing Trend Analysis by Region, 2025–2035
TABLE 26: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Value Chain Analysis
TABLE 27: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Supply Chain Analysis
TABLE 28: U.S. Ambulatory Surgery Center Anesthesia Machines Market: OEM, Distributor and Refurbisher Channel Analysis
TABLE 29: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Digitalization and Connected Anesthesia Impact
TABLE 30: U.S. Ambulatory Surgery Center Anesthesia Machines Market: FDA Regulatory Framework Analysis
TABLE 31: U.S. Ambulatory Surgery Center Anesthesia Machines Market: CMS ASC Coverage and Reimbursement Landscape
TABLE 32: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Accreditation, Certification and State Licensing Landscape
TABLE 33: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Equipment Safety, Maintenance and Recall Landscape
TABLE 34: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Environmental Impact of Low-Flow Anesthesia
TABLE 35: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Import/Export, Tariff and Geopolitical Impact
TABLE 36: U.S. Ambulatory Surgery Center Anesthesia Machines Market: ASC Capital Equipment Decision Framework
TABLE 37: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Product Type Snapshot, 2025
TABLE 38: Segment Dashboard; Definition and Scope, by Product Type
TABLE 39: U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Product Type, 2021–2035 (US$ Billion)
TABLE 40: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Segment Share Analysis, by Product Type, 2025 & 2035 (%)
TABLE 41: Integrated Anesthesia Workstations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 42: Compact Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 43: Portable and Mobile Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 44: Modular and Standalone Anesthesia Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 45: Advanced High-Acuity Anesthesia Workstations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 46: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Technology Snapshot, 2025
TABLE 47: Segment Dashboard; Definition and Scope, by Technology
TABLE 48: U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Technology, 2021–2035 (US$ Billion)
TABLE 49: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Segment Share Analysis, by Technology, 2025 & 2035 (%)
TABLE 50: Electronic and Digitally Controlled Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 51: Conventional Pneumatic and Mechanically Controlled Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 52: Low-Flow and Closed/Semi-Closed Circuit Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 53: Automated Gas-Control Systems Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 54: Connectivity-Enabled and Smart Anesthesia Workstations Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 55: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Surgical Specialty Snapshot, 2025
TABLE 56: Segment Dashboard; Definition and Scope, by Surgical Specialty
TABLE 57: U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Surgical Specialty, 2021–2035 (US$ Billion)
TABLE 58: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Segment Share Analysis, by Surgical Specialty, 2025 & 2035 (%)
TABLE 59: Orthopedic and Total Joint Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 60: Spine Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 61: Gastroenterology and Advanced Endoscopy Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 62: Ophthalmology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 63: ENT and Oral/Maxillofacial Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 64: Urology and Gynecology Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 65: General Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 66: Plastic, Reconstructive and Other Ambulatory Surgery Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 67: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Facility Model Snapshot, 2025
TABLE 68: Segment Dashboard; Definition and Scope, by Facility Model
TABLE 69: U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Facility Model, 2021–2035 (US$ Billion)
TABLE 70: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Segment Share Analysis, by Facility Model, 2025 & 2035 (%)
TABLE 71: Independent and Physician-Owned ASCs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 72: Hospital and Health-System-Affiliated ASCs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 73: Physician–Hospital Joint-Venture ASCs Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 74: Corporate, Multisite and Specialty ASC Networks Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 75: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Procurement Model Snapshot, 2025
TABLE 76: Segment Dashboard; Definition and Scope, by Procurement Model
TABLE 77: U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Procurement Model, 2021–2035 (US$ Billion)
TABLE 78: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Segment Share Analysis, by Procurement Model, 2025 & 2035 (%)
TABLE 79: New Equipment Purchases Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 80: Refurbished and Pre-Owned Equipment Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 81: Leasing and Equipment Financing Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 82: Managed Equipment, Service-Bundled and Enterprise Contracts Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 83: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Regional Snapshot, 2025
TABLE 84: Segment Dashboard; Definition and Scope, by Region
TABLE 85: U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Region, 2021–2035 (US$ Billion)
TABLE 86: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Regional Share Analysis, 2025 & 2035 (%)
TABLE 87: West Region U.S. Ambulatory Surgery Center Anesthesia Machines Market: Regional Overview and Trends
TABLE 88: West Region U.S. Ambulatory Surgery Center Anesthesia Machines Market: Key Manufacturers and Procurement Ecosystem
TABLE 89: West Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 90: West Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Product Type and Technology, 2021–2035 (US$ Billion)
TABLE 91: West Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Surgical Specialty, Facility Model and Procurement Model, 2021–2035 (US$ Billion)
TABLE 92: California Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 93: Washington Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 94: Arizona Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 95: Colorado Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 96: Oregon Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 97: Utah Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 98: Nevada Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 99: New Mexico Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 100: Idaho Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 101: Montana Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 102: Wyoming Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 103: Alaska Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 104: Hawaii Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 105: Northeast Region U.S. Ambulatory Surgery Center Anesthesia Machines Market: Regional Overview and Trends
TABLE 106: Northeast Region U.S. Ambulatory Surgery Center Anesthesia Machines Market: Key Manufacturers and Procurement Ecosystem
TABLE 107: Northeast Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 108: Northeast Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Product Type and Technology, 2021–2035 (US$ Billion)
TABLE 109: Northeast Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Surgical Specialty, Facility Model and Procurement Model, 2021–2035 (US$ Billion)
TABLE 110: New York Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 111: Massachusetts Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 112: New Jersey Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 113: Pennsylvania Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 114: Connecticut Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 115: Maine Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 116: Vermont Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 117: New Hampshire Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 118: Rhode Island Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 119: Delaware Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 120: South Region U.S. Ambulatory Surgery Center Anesthesia Machines Market: Regional Overview and Trends
TABLE 121: South Region U.S. Ambulatory Surgery Center Anesthesia Machines Market: Key Manufacturers and Procurement Ecosystem
TABLE 122: South Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 123: South Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Product Type and Technology, 2021–2035 (US$ Billion)
TABLE 124: South Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Surgical Specialty, Facility Model and Procurement Model, 2021–2035 (US$ Billion)
TABLE 125: Texas Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 126: Florida Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 127: Georgia Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 128: North Carolina Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 129: Tennessee Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 130: South Carolina Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 131: Alabama Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 132: Mississippi Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 133: Louisiana Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 134: Arkansas Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 135: Kentucky Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 136: Oklahoma Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 137: Virginia Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 138: Maryland Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 139: West Virginia Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 140: Midwest Region U.S. Ambulatory Surgery Center Anesthesia Machines Market: Regional Overview and Trends
TABLE 141: Midwest Region U.S. Ambulatory Surgery Center Anesthesia Machines Market: Key Manufacturers and Procurement Ecosystem
TABLE 142: Midwest Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by State, 2021–2035 (US$ Billion)
TABLE 143: Midwest Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Product Type and Technology, 2021–2035 (US$ Billion)
TABLE 144: Midwest Region U.S. Ambulatory Surgery Center Anesthesia Machines Market, by Surgical Specialty, Facility Model and Procurement Model, 2021–2035 (US$ Billion)
TABLE 145: Illinois Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 146: Ohio Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 147: Michigan Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 148: Minnesota Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 149: Indiana Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 150: Wisconsin Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 151: Missouri Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 152: Iowa Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 153: Kansas Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 154: Nebraska Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 155: North Dakota Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 156: South Dakota Ambulatory Surgery Center Anesthesia Machines Market Size and Forecast, 2021–2035 (US$ Billion)
TABLE 157: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Competitive Landscape Snapshot, 2025
TABLE 158: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Key Company Market Share Analysis, 2025
TABLE 159: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Company Positioning Matrix
TABLE 160: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Product, Pricing, Service and ASC Suitability Benchmarking
TABLE 161: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Strategic Developments, Partnerships, M&A and Product Launches
TABLE 162: GE HealthCare: Company Profile
TABLE 163: Drägerwerk AG & Co. KGaA / Dräger, Inc.: Company Profile
TABLE 164: Mindray North America: Company Profile
TABLE 165: Getinge AB: Company Profile
TABLE 166: Penlon Limited: Company Profile
TABLE 167: Beijing Aeonmed Co., Ltd.: Company Profile
TABLE 168: Shenzhen Comen Medical Instruments Co., Ltd.: Company Profile
TABLE 169: Shenzhen Prunus Medical Co., Ltd.: Company Profile
TABLE 170: Infinium Medical: Company Profile
TABLE 171: Avante Health Solutions: Company Profile
TABLE 172: Soma Tech Intl: Company Profile
TABLE 173: USOC Medical: Company Profile
TABLE 174: Masimo Corporation: Company Profile
TABLE 175: Nihon Kohden America: Company Profile
TABLE 176: Philips: Company Profile
TABLE 177: Medtronic: Company Profile
TABLE 178: Teleflex Incorporated: Company Profile
TABLE 179: Ambu A/S: Company Profile
TABLE 180: Cardinal Health: Company Profile
TABLE 181: Medline Industries, LP: Company Profile
TABLE 182: B. Braun Medical Inc.: Company Profile
TABLE 183: ICU Medical, Inc.: Company Profile
TABLE 184: BD: Company Profile
TABLE 185: Intersurgical Inc.: Company Profile
TABLE 186: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Future Market Scenario Analysis, 2026–2035
TABLE 187: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Disruptive Technologies Impact Matrix
TABLE 188: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Future ASC Procedure Migration Impact
TABLE 189: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Future Equipment Replacement Cycle
TABLE 190: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Emerging Business Trends
TABLE 191: U.S. Ambulatory Surgery Center Anesthesia Machines Market: OEM, Refurbisher and Service Provider Opportunity Matrix
TABLE 192: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Investment Prioritization and High-Growth State Matrix
TABLE 193: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Strategic Recommendations for Manufacturers
TABLE 194: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Strategic Recommendations for ASC Operators
TABLE 195: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Strategic Recommendations for Investors and Private Equity Firms
TABLE 196: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Strategic Recommendations for Distributors and Refurbishers
TABLE 197: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Strategic Recommendations for New Entrants
TABLE 198: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Go-to-Market and Enterprise Contracting Strategy
TABLE 199: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Product Positioning, Pricing and Service-Bundle Guidance
TABLE 200: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Scope and Data Use Limitation
TABLE 201: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Market Sizing and Forecasting Limitation
TABLE 202: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Regulatory, Reimbursement and State-Level Estimate Limitation
TABLE 203: U.S. Ambulatory Surgery Center Anesthesia Machines Market: Legal and Third-Party Data Disclaimer

List of Figures

FIGURE 1: U.S. Ambulatory Surgery Center Anesthesia Machines Market Segmentation
FIGURE 2: Market Research Methodology
FIGURE 3: ASC Anesthesia Machine Market Ecosystem
FIGURE 4: Stakeholder Ecosystem
FIGURE 5: Market Attractiveness Analysis
FIGURE 6: U.S. Ambulatory Surgery Center Anesthesia Machines Market Size, Historical Trend Analysis, 2021–2024 (US$ Billion)
FIGURE 7: U.S. Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2026–2035 (US$ Billion)
FIGURE 8: U.S. Ambulatory Surgery Center Anesthesia Machines Market Year-wise Growth Curve, 2021–2035
FIGURE 9: ASC Installed-Base and High-Growth Opportunity Map
FIGURE 10: Market Dynamics
FIGURE 11: Innovation & Patent Landscape, 2021–2025
FIGURE 12: ASC Clinical Workflow Economics Framework
FIGURE 13: Anesthesia Machine Total Cost of Ownership Framework
FIGURE 14: ASC Capital Procurement Decision Framework
FIGURE 15: New-Build vs. Replacement Demand Roadmap
FIGURE 16: PESTEL Analysis
FIGURE 17: Porter’s Five Forces Analysis
FIGURE 18: Value Chain Analysis
FIGURE 19: Supply Chain Analysis
FIGURE 20: OEM, Distributor and Refurbisher Channel Framework
FIGURE 21: CMS ASC Reimbursement and FDA Regulatory Framework
FIGURE 22: Anesthesia Machine Safety, Maintenance and Recall Framework
FIGURE 23: Low-Flow Anesthesia and Environmental Impact Framework
FIGURE 24: Product Type Segment Market Share Analysis, 2025 & 2035
FIGURE 25: Product Type Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 26: Integrated Anesthesia Workstations Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 27: Compact Anesthesia Machines Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 28: Portable, Modular and High-Acuity Anesthesia Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 29: Technology Segment Market Share Analysis, 2025 & 2035
FIGURE 30: Technology Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 31: Electronic and Digitally Controlled Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 32: Low-Flow and Automated Gas-Control Systems Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 33: Connectivity-Enabled Smart Anesthesia Workstations Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 34: Surgical Specialty Segment Market Share Analysis, 2025 & 2035
FIGURE 35: Surgical Specialty Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 36: Orthopedic, Total Joint and Spine Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 37: Gastroenterology and Ophthalmology Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 38: ENT, Urology, Gynecology and General Surgery Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 39: Facility Model Segment Market Share Analysis, 2025 & 2035
FIGURE 40: Facility Model Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 41: Independent and Physician-Owned ASC Market Trend Analysis
FIGURE 42: Hospital-Affiliated, Joint-Venture and Multisite ASC Market Trend Analysis
FIGURE 43: Procurement Model Segment Market Share Analysis, 2025 & 2035
FIGURE 44: Procurement Model Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 45: New vs. Refurbished Anesthesia Machine Procurement Analysis
FIGURE 46: Leasing, Managed Equipment and Enterprise Contracting Framework
FIGURE 47: Regional Segment Market Share Analysis, 2025 & 2035
FIGURE 48: Regional Segment Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 49: West Region Market Share Analysis by State, 2025
FIGURE 50: West Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 51: California Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 52: Washington Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 53: Arizona Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 54: Colorado Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 55: Oregon Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 56: Utah Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 57: Nevada Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 58: New Mexico Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 59: Idaho Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 60: Montana Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 61: Wyoming Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 62: Alaska Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 63: Hawaii Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 64: Northeast Region Market Share Analysis by State, 2025
FIGURE 65: Northeast Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 66: New York Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 67: Massachusetts Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 68: New Jersey Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 69: Pennsylvania Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 70: Connecticut Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 71: Maine Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 72: Vermont Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 73: New Hampshire Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 74: Rhode Island Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 75: Delaware Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 76: South Region Market Share Analysis by State, 2025
FIGURE 77: South Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 78: Texas Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 79: Florida Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 80: Georgia Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 81: North Carolina Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 82: Tennessee Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 83: South Carolina Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 84: Alabama Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 85: Mississippi Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 86: Louisiana Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 87: Arkansas Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 88: Kentucky Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 89: Oklahoma Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 90: Virginia Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 91: Maryland Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 92: West Virginia Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 93: Midwest Region Market Share Analysis by State, 2025
FIGURE 94: Midwest Region Market Size Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 95: Illinois Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 96: Ohio Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 97: Michigan Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 98: Minnesota Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 99: Indiana Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 100: Wisconsin Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 101: Missouri Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 102: Iowa Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 103: Kansas Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 104: Nebraska Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 105: North Dakota Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 106: South Dakota Ambulatory Surgery Center Anesthesia Machines Market Size, Forecast and Trend Analysis, 2021–2035 (US$ Billion)
FIGURE 107: Competitive Landscape; Key Company Market Share Analysis, 2025
FIGURE 108: Company Positioning Matrix
FIGURE 109: Key Player Product, Pricing and Service Benchmarking
FIGURE 110: Strategic Developments, Partnerships, M&A and Product Launches
FIGURE 111: U.S. ASC Anesthesia Machine Competitive Ecosystem
FIGURE 112: Future Market Scenario Analysis, 2026–2035
FIGURE 113: Disruptive Technologies Impact Matrix
FIGURE 114: Low-Flow and Automated Gas-Control Technology Roadmap
FIGURE 115: Connected Anesthesia and Digital Integration Roadmap
FIGURE 116: ASC Procedure Migration and Equipment Replacement Opportunity Map
FIGURE 117: Investment Prioritization and High-Growth State Matrix
FIGURE 118: Strategic Growth Roadmap for U.S. ASC Anesthesia Machine Companies
FIGURE 119: Go-to-Market and Enterprise Contracting Strategy Framework
FIGURE 120: Product Positioning, Pricing and Service-Bundle Framework
FIGURE 121: State-Level Commercial Prioritization Framework
FIGURE 122: Report Scope, Limitations and Disclaimer Framework